Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

2003307 citationsJournal Articlebronze Open Access

Authors

Berthe M.P. Aleman · The Netherlands Cancer Institute

John Raemaekers · Radboud University Nijmegen

Umberto Tirelli

Roberto Bortolus

Mars B. van ’t Veer · Erasmus MC

Marnix L.M. Lybeert · Radboud University Nijmegen

Jo J. Keuning · Máxima Medisch Centrum

Patrice Carde

Abstract

Involved-field radiotherapy did not improve the outcome in patients with advanced-stage Hodgkin's lymphoma who had a complete remission after MOPP-ABV chemotherapy. Radiotherapy may benefit patients with a partial response after chemotherapy.

Topics & Keywords

Lymphoma Diagnosis and Treatment Lung Cancer Treatments and Mutations CNS Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 348, Issue 24, pp. 2396-2406

DOI: 10.1056/nejmoa022628

Field-Weighted Citation Impact: 13.91